OR WAIT null SECS
September 13, 2021
FDA’s recommended guidance is for a system that ‘does not exist, cannot be built by 2023, and poses unacceptable security and compliance risks,’ says alliance
June 08, 2021
“Aggregation” and “inference” are specifically allowed, under draft guidance
May 13, 2021
Pair of life-sciences data powerhouses are immersed in dispute over their respective data services for pharma sales and marketing
May 07, 2021
Nationally and internationally, the logistics service providers for life sciences see a new vista
July 28, 2020
July 24, 2020
Steady progress is occurring in the global effort to track pharmaceutical distribution, even as new technical and business opportunities appear